Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-26 7:57 pm Sale | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 2,813,837 5.4% | -834,459 (-22.87%) | View |
| 2024-02-20 7:11 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 3,648,296 6.9% | 171,215 (+4.92%) | View |
| 2024-02-20 7:11 pm Purchase | 13D | INOZYME PHARMA INC INZY | Sofinnova Venture Partners X L.P. | 4,280,308 6.9% | 2,252,000 (+111.03%) | View |
| 2024-02-20 7:09 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,807,315 13.8% | 23,683 (+0.63%) | View |
| 2023-06-20 8:56 pm Sale | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X L.P. | 1,439,649 3.8% | -386,975 (-21.19%) | View |
| 2023-03-01 1:38 pm Sale | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X L.P. | 0 0% | -6,109,360 (Position Closed) | View |
| 2023-02-13 8:43 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 3,477,081 8.3% | 285,714 (+8.95%) | View |
| 2023-02-03 7:24 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,783,632 15.4% | 23,558 (+0.63%) | View |
| 2023-02-03 7:11 pm Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X L.P. | 1,826,624 5.3% | 97,272 (+5.62%) | View |
| 2023-02-03 7:07 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 3,191,367 11.5% | 276,591 (+9.49%) | View |
| 2022-08-19 5:38 pm Purchase | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X L.P. | 6,109,360 14.3% | 535,411 (+9.61%) | View |
| 2022-02-14 6:45 pm Purchase | 13D | Y-MABS THERAPEUTICS INC YMAB | Sofinnova Venture Partners X L.P. | 2,271,611 5.2% | 160,222 (+7.59%) | View |
| 2022-01-21 3:19 pm Purchase | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X L.P. | 5,573,949 15.3% | 5,573,949 (New Position) | View |
| 2021-07-13 1:49 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,760,074 16.3% | 3,760,074 (New Position) | View |
| 2021-05-24 1:46 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 2,914,776 14.5% | 2,914,776 (New Position) | View |
| 2021-03-04 06:20 am Purchase | 13D | INOZYME PHARMA INC INZY | Sofinnova Venture Partners X L.P. | 2,028,308 8.7% | 2,028,308 (New Position) | View |
| 2021-02-16 2:14 pm Purchase | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Sofinnova Venture Partners X L.P. | 2,754,437 8% | 2,754,437 (New Position) | View |
| 2019-07-03 12:54 pm Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X L.P. | 1,729,352 7.4% | 1,729,352 (New Position) | View |